TG Therapeutics, Inc. (TGTX)
42.63
+0.66
(+1.57%)
USD |
NASDAQ |
May 07, 13:24
TG Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Precision BioSciences, Inc. | -0.114M |
| Krystal Biotech, Inc. | -63.58M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
| Geron Corp. | -- |
| Viking Therapeutics, Inc. | 54.19M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -24.99M |
| Free Cash Flow Per Share (Quarterly) | 0.1229 |
| Free Cash Flow to Equity (Quarterly) | 19.60M |
| Free Cash Flow to Firm (Quarterly) | 22.93M |
| Free Cash Flow Yield | -0.36% |